Skip to main content

$0.003 -0.001 (-16.67%)

High

$0.00

Low

$0.00

Trades

1

Turnover

$54

Volume

21,427
30 June 2023 at 2:30pm
Register to track ADR and receive email alerts.
Subject
ADR Ann: Application for quotation of securities - ADR

ADR Ann: Change of Auditor

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: Change of Company Secretary

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: US FDA clearance of Adherium's Hailie for Teva inhalers

ADR Ann: Ceasing to be a substantial holder

ADR Ann: Half Yearly Report and Accounts

ADR Ann: Change in substantial holding

ADR Ann: Becoming a substantial holder

ADR Ann: Ceasing to be a substantial holder

ADR Ann: Adherium Exhibiting at AAAAI 2023 Annual Meeting

ADR Ann: Becoming a substantial holder

ADR Ann: Change in substantial holding

ADR Ann: Adherium launches new Interactive Investor Hub

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: Notification regarding unquoted securities - ADR

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Ellipta Production and Market Release

ADR Ann: ADR TGA Approval for Next Generation Sensors

ADR Ann: Adherium Awarded UK NHS SBRI Healthcare Monitoring Project

ADR Ann: Adherium to present at J.P. Morgan Healthcare Conference

ADR Ann: Ceasing to be a substantial holder

ADR Ann: Change in substantial holding (Trudell Medical)

ADR Ann: Change of Director's Interest Notice (G Baran)

ADR Ann: Cleansing notice under s708A of the Corporations Act

ADR Ann: Notification regarding unquoted securities - ADR

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Notification regarding unquoted securities - ADR

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Adherium Share Purchase Plan Offer Results

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Adherium receives $1.3m Australian R&D Tax Incentive

ADR Ann: Final Director's Interest Notice

ADR Ann: Results of Meeting and Director Update

ADR Ann: CEO's Address to Shareholders at AGM

ADR Ann: US FDA clearance of Adherium's Hailie for GSK inhalers

ADR Ann: Adherium exhibiting at 2022 BTS Winter Meeting

ADR Ann: Adherium SPP and Shortfall Offers Prospectus

ADR Ann: Update - Proposed issue of securities - ADR

ADR Ann: Update - Proposed issue of securities - ADR

ADR Ann: Adherium Exhibiting at ACAAI 2022

ADR Ann: Becoming a substantial holder

ADR Ann: Change of Director's Interest Notice (L Panaccio)

ADR Ann: Change of Director's Interest Notice (G Baran)

ADR Ann: Change in substantial holding

ADR Ann: Change in substantial holding

ADR Ann: Disclosure of Long Equity Derivative Positions

ADR Ann: Change in substantial holding

ADR Ann: Notice of Annual General Meeting/Proxy Form

Register to track ADR and receive email alerts.

Similar Companies

VHT